Pfizer PFE Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $63.32B+1.4% | $62.58B-1.6% | $62.79B+3.9% | $63.83B+13.5% | $62.46B+11.6% | ||
| $16.77B-3.2% | $16.07B-10.0% | $16.7B-14.4% | $17.8B-24.3% | $17.32B-26.1% | ||
| $46.55B+3.1% | $46.51B+1.6% | $46.08B+12.6% | $46.04B+40.7% | $45.15B+38.9% | ||
| 73.5%+1.2pp | 74.3%+2.4pp | 73.4%+5.7pp | 72.1%+13.9pp | 72.3%+14.2pp | ||
| $13.72B-3.8% | $13.79B-6.4% | $13.91B-7.5% | $13.96B-7.3% | $14.27B-3.9% | ||
| —— | —— | $9.16B— | $10.54B— | $7.4B— | ||
| $384M+175% | -$266M-850% | -$685M-70.4% | -$235M+85.3% | -$510M+66.8% | ||
| —— | —— | $9.83B— | $10.75B— | $7.88B— | ||
| —— | —— | $1.72— | $1.88— | $1.38— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Pfizer's revenue?
- Pfizer (PFE) generated $63.3B in revenue over the trailing twelve months, up 1.4% year over year.
- Is Pfizer profitable?
- Pfizer reported $12.1B in net income over the trailing twelve months, a 15.7% net margin.
- What is Pfizer's earnings per share?
- Pfizer's diluted EPS over the trailing twelve months is $2.12.
- Where does Pfizer's income statement data come from?
- Every line is extracted from Pfizer's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
